Process View
The network for 'regulation of glycogen biosynthetic process' in your query organism is displayed on the left, if relationships are supported by the integrated data. Moving any of the genes in that network will simultaneously update the homologs in the networks displayed to the right (if they exist). Additionally, hovering over any nodes will highlight the identified functionally similar homologs in the other networks. Last, the bar above the networks allows you to remove/add additional organisms. Simily drag and drop the organism names in the desired order.
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen.
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
Insr | insulin receptor | 0.983 | |
Grb10 | growth factor receptor bound protein 10 | 0.808 | |
Lepr | leptin receptor | 0.621 | |
Irs2 | insulin receptor substrate 2 | 0.393 | |
Gnas | GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus | 0.176 | |
Igf2 | insulin-like growth factor 2 | 0.141 | |
Ghr | growth hormone receptor | 0.132 | |
Igf1r | insulin-like growth factor I receptor | 0.099 | |
Pim1 | proviral integration site 1 | 0.092 | |
Igf2r | insulin-like growth factor 2 receptor | 0.044 | |
Ins2 | insulin II | 0.037 | |
Rps2 | ribosomal protein S2 | 0.024 | |
Esr1 | estrogen receptor 1 (alpha) | 0.022 | |
Pim3 | proviral integration site 3 | 0.021 | |
Nos3 | nitric oxide synthase 3, endothelial cell | 0.021 | |
Pnpla2 | patatin-like phospholipase domain containing 2 | 0.019 | |
Cebpb | CCAAT/enhancer binding protein (C/EBP), beta | 0.017 | |
Akt1 | thymoma viral proto-oncogene 1 | 0.017 | |
Cav1 | caveolin 1, caveolae protein | 0.016 | |
Drd2 | dopamine receptor D2 | 0.015 | |
Acr | acrosin prepropeptide | 0.014 | |
Lep | leptin | 0.013 | |
Nos1 | nitric oxide synthase 1, neuronal | 0.012 | |
Pparg | peroxisome proliferator activated receptor gamma | 0.011 | |
Eef1a1 | eukaryotic translation elongation factor 1 alpha 1 | 0.011 | |
Rps3 | ribosomal protein S3 | 0.011 | |
Lipe | lipase, hormone sensitive | 0.011 | |
Nedd4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.010 | |
Pik3r1 | phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) | 0.010 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
INSR | insulin receptor | 1.000 | |
GRB10 | growth factor receptor-bound protein 10 | 0.996 | |
IRS1 | insulin receptor substrate 1 | 0.989 | |
IRS2 | insulin receptor substrate 2 | 0.936 | |
IGF1R | insulin-like growth factor 1 receptor | 0.793 | |
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.694 | |
PRKCZ | protein kinase C, zeta | 0.626 | |
ITGB1BP3 | integrin beta 1 binding protein 3 | 0.276 | |
SH3RF1 | SH3 domain containing ring finger 1 | 0.221 | |
SH2B1 | SH2B adaptor protein 1 | 0.190 | |
LZTS2 | leucine zipper, putative tumor suppressor 2 | 0.176 | |
NOXA1 | NADPH oxidase activator 1 | 0.174 | |
NCF1 | neutrophil cytosolic factor 1 | 0.151 | |
STAT5B | signal transducer and activator of transcription 5B | 0.120 | |
IGF2R | insulin-like growth factor 2 receptor | 0.103 | |
PPP1R2 | protein phosphatase 1, regulatory (inhibitor) subunit 2 | 0.084 | |
CREB1 | cAMP responsive element binding protein 1 | 0.069 | |
PRKCB | protein kinase C, beta | 0.069 | |
PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.068 | |
ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | 0.063 | |
PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.062 | |
RPTOR | regulatory associated protein of MTOR, complex 1 | 0.056 | |
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.055 | |
PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.049 | |
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.044 | |
RAB6A | RAB6A, member RAS oncogene family | 0.044 | |
ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.043 | |
AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.041 | |
RAB14 | RAB14, member RAS oncogene family | 0.039 | |
PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.038 | |
LAT | linker for activation of T cells | 0.036 | |
MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.035 | |
EGFR | epidermal growth factor receptor | 0.029 | |
PTPRZ1 | protein tyrosine phosphatase, receptor-type, Z polypeptide 1 | 0.028 | |
SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | 0.026 | |
PICK1 | protein interacting with PRKCA 1 | 0.023 | |
DNAJB9 | DnaJ (Hsp40) homolog, subfamily B, member 9 | 0.023 | |
DYRK1B | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | 0.023 | |
GRB14 | growth factor receptor-bound protein 14 | 0.023 | |
PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.021 | |
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.020 | |
HIPK2 | homeodomain interacting protein kinase 2 | 0.020 | |
EPM2A | epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) | 0.019 | |
OSBP | oxysterol binding protein | 0.018 | |
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.018 | |
GCKR | glucokinase (hexokinase 4) regulator | 0.018 | |
PPP1CA | protein phosphatase 1, catalytic subunit, alpha isozyme | 0.017 | |
PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.017 | |
CDCP1 | CUB domain containing protein 1 | 0.015 | |
PRKCA | protein kinase C, alpha | 0.015 | |
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.015 | |
CYBA | cytochrome b-245, alpha polypeptide | 0.015 | |
PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.015 | |
CCND1 | cyclin D1 | 0.014 | |
EPOR | erythropoietin receptor | 0.014 | |
CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.013 | |
ACBD3 | acyl-CoA binding domain containing 3 | 0.013 | |
MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.013 | |
TRIM9 | tripartite motif containing 9 | 0.013 | |
RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.012 | |
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.012 | |
VHL | von Hippel-Lindau tumor suppressor | 0.012 | |
RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 0.012 | |
NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.012 | |
HMOX2 | heme oxygenase (decycling) 2 | 0.012 | |
SESN2 | sestrin 2 | 0.012 | |
BMX | BMX non-receptor tyrosine kinase | 0.011 | |
SPRED1 | sprouty-related, EVH1 domain containing 1 | 0.011 | |
LMTK2 | lemur tyrosine kinase 2 | 0.010 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
Serinc1 | serine incorporator 1 | 0.036 | |
Tspyl1 | TSPY-like 1 | 0.017 | |
Eef2 | eukaryotic translation elongation factor 2 | 0.016 | |
Snrpb | small nuclear ribonucleoprotein polypeptides B and B1 | 0.012 | |
Gnb2 | guanine nucleotide binding protein (G protein), beta polypeptide 2 | 0.011 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
GSY1 | Gsy1p | 0.988 | |
GSY2 | Gsy2p | 0.987 | |
GIP2 | Gip2p | 0.859 | |
GLG2 | Glg2p | 0.797 | |
GPH1 | Gph1p | 0.441 | |
GLG1 | Glg1p | 0.418 | |
UGP1 | Ugp1p | 0.303 | |
HXK1 | Hxk1p | 0.192 | |
PIG2 | Pig2p | 0.165 | |
FMP48 | Fmp48p | 0.154 | |
PCL10 | Pcl10p | 0.093 | |
GLC7 | Glc7p | 0.089 | |
YLR177W | hypothetical protein | 0.081 | |
YCL042W | hypothetical protein | 0.063 | |
YGR205W | hypothetical protein | 0.061 | |
PCL8 | Pcl8p | 0.061 | |
PSK1 | Psk1p | 0.059 | |
HXT7 | Hxt7p | 0.056 | |
BDH1 | Bdh1p | 0.043 | |
CAK1 | Cak1p | 0.032 | |
PHO81 | Pho81p | 0.030 | |
MAL32 | Mal32p | 0.029 | |
HXT6 | Hxt6p | 0.026 | |
YIL151C | hypothetical protein | 0.026 | |
TRR1 | Trr1p | 0.024 | |
GLN1 | Gln1p | 0.022 | |
SUC2 | Suc2p | 0.022 | |
YLR264C-A | hypothetical protein | 0.021 | |
SAP4 | Sap4p | 0.021 | |
LEU2 | Leu2p | 0.021 | |
SRD1 | Srd1p | 0.020 | |
GLC3 | Glc3p | 0.020 | |
MRK1 | Mrk1p | 0.020 | |
YJL181W | hypothetical protein | 0.019 | |
CMK1 | Cmk1p | 0.019 | |
PCL2 | Pcl2p | 0.019 | |
HEM15 | Hem15p | 0.018 | |
GAC1 | Gac1p | 0.017 | |
YLR162W | hypothetical protein | 0.017 | |
YOL038C-A | hypothetical protein | 0.017 | |
ARP10 | Arp10p | 0.017 | |
HRR25 | Hrr25p | 0.016 | |
RPS20 | Rps20p | 0.016 | |
RHO1 | Rho1p | 0.016 | |
YOR352W | hypothetical protein | 0.016 | |
GDB1 | Gdb1p | 0.016 | |
BCK2 | Bck2p | 0.016 | |
YNR014W | hypothetical protein | 0.016 | |
MER1 | Mer1p | 0.015 | |
CHA1 | Cha1p | 0.015 | |
LAP4 | Lap4p | 0.015 | |
PCL1 | Pcl1p | 0.015 | |
YAR068W | hypothetical protein | 0.014 | |
GYL1 | Gyl1p | 0.014 | |
SSA4 | Ssa4p | 0.014 | |
THO2 | Tho2p | 0.014 | |
KIN28 | Kin28p | 0.014 | |
PNS1 | Pns1p | 0.014 | |
HXT3 | Hxt3p | 0.014 | |
HPF1 | Hpf1p | 0.014 | |
CPD1 | Cpd1p | 0.014 | |
URA3 | Ura3p | 0.014 | |
ENO1 | Eno1p | 0.014 | |
MBR1 | Mbr1p | 0.013 | |
CUP1-1 | Cup1-1p | 0.013 | |
HOR7 | Hor7p | 0.013 | |
ZPS1 | Zps1p | 0.013 | |
ICS2 | Ics2p | 0.012 | |
PGM2 | Pgm2p | 0.012 | |
YHR009C | hypothetical protein | 0.012 | |
ATP6 | Atp6p | 0.012 | |
YBR013C | hypothetical protein | 0.012 | |
YMR210W | hypothetical protein | 0.012 | |
SPL2 | Spl2p | 0.012 | |
RGI1 | Rgi1p | 0.012 | |
ARG8 | Arg8p | 0.012 | |
PTI1 | Pti1p | 0.011 | |
YHB1 | Yhb1p | 0.011 | |
OPT2 | Opt2p | 0.011 | |
AZF1 | Azf1p | 0.011 | |
YIR035C | hypothetical protein | 0.011 | |
RPS5 | Rps5p | 0.011 | |
DAL7 | Dal7p | 0.011 | |
YEL023C | hypothetical protein | 0.011 | |
YOL013W-A | hypothetical protein | 0.011 | |
URA8 | Ura8p | 0.011 | |
CLG1 | Clg1p | 0.011 | |
REE1 | Ree1p | 0.011 | |
YML053C | hypothetical protein | 0.010 | |
MF(ALPHA)2 | Mf(alpha)2p | 0.010 | |
YLR042C | hypothetical protein | 0.010 | |
YKR075C | hypothetical protein | 0.010 | |
PCD1 | Pcd1p | 0.010 | |
PTR2 | Ptr2p | 0.010 | |
AUA1 | Aua1p | 0.010 | |
SWC7 | Swc7p | 0.010 | |
SOR2 | Sor2p | 0.010 |